 |
|
|
RDB Events
6/23/2008
“The FTC v. Cephalon case: What does it mean for future brand-generic patent settlements?” ABA Section of Antitrust Law
Wilson Sonsini Goodrich & Rosati, Washington, DC
6/19/2008
“A Dickensian View of Pharmaceutical Antitrust: Bleak House or Great Expectations?” Generic Drug Summit, Institute for International Research
Ritz Carlton, Washington, DC
6/5/2008
“Panel Discussion with Partners,” Lawyer’s Forum
Capital Hilton
5/15/2008
“Choosing the Best Forum For Your Case,” American Conference Institute’s 17th National Advanced Forum on Bad Faith Litigation
San Francisco, CA
5/8/2008
“Overturning the SEC ‘Broker Dealer Rule’ - What to Expect Going Forward,” 2008 fi360 National Conference
4/24/2008
“Should We Allow Brand Companies to Pay Generics to End Patent Challenges: James J. Kirkpatrick Meet Shana Alexander,” Law Seminars International, Seminar on Pharmaceutical Antitrust
Westin Washington DC City Center
3/3/2008
February In-House Counsel Antitrust Update for the ABA Section of Antitrust Law
Teleconference
2/28/2008
“Testing the Waters: Discovering the Latest Currents in Insurance Coverage Law,” ABA TIPS Insurance Coverage Litigation Committee 2008 Mid-Year Meeting
2/21/2008
“Recognizing Price-Fixing and Market-Allocation Conspiracies”
Los Angeles County Bar Association Conference Center
2/15/2008
“Summary of Intellectual Property Law Basics” and Expanded Seminar, Motorcycle Industry Council’s Annual Meeting
Indianapolis, IN
 More
|
|